Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

Clinical trial NCT00499655 · COMPLETED

Trial details

NCT number: NCT00499655
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer

Start date: 2007-11-01
Primary completion: 2016-12-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.